Sep 2022

Text & Data Mining in Drug Discovery: A Conversation with Springer Nature

Hear Mark Davies, SVP Informatics and Data, speak to Springer Nature about how BenevolentAI is leveraging the scientific literature to expedite drug discovery.
Aug 2022

Innovation Week: pushing the boundaries of AI in drug discovery

BenevolentAI’s Innovation Week enables our team to reflect, build and test new ideas and push the boundaries of AI in drug discovery.
Apr 2022

BenevolentAI · AI-Enabled Drug Discovery

Advanced technologies, combined with an exponential increase in biomedical data and research, provide an unparalleled opportunity to unravel the mysteries of diseases that have gone untreated for too long.
Jan 2022

Joanna Shields • J.P. Morgan Health Care Conference 2022

Joanna Shields, CEO of BenevolentAI, a clinical-stage AI drug discovery company, presented at the 40th Annual J.P. Morgan Healthcare Conference on Monday, 10th January.